2764-81-0

Basic information

• Product Name: 15-Nonacosanol
• Synonyms: 15-Nonacosanol
• CAS NO: 2764-81-0
• Molecular Formula: C₂₉H₆₀O
• Molecular Weight: 424.7861
• Mol File: 2764-81-0.mol

Chemical Properties

• Melting Point: 85-85.9 °C
• Boiling Point: 463.0±13.0 °C(Predicted)
• Appearance: /
• Density: 0.840±0.06 g/cm3(Predicted)
• PKA: 15.22±0.20(Predicted)
• CAS DataBase Reference: 15-Nonacosanol(CAS DataBase Reference)
• NIST Chemistry Reference: 15-Nonacosanol(2764-81-0)
• EPA Substance Registry System: 15-Nonacosanol(2764-81-0)

Safety Data

• Hazardous Substances Data: 2764-81-0(Hazardous Substances Data)

Usage

Appearance

Waxy, crystalline solid at room temperature

Solubility

Insoluble in water, soluble in most organic solvents

Natural occurrence

Commonly found in plant waxes and adjuvants used in agricultural products

Potential applications

Medicine, agriculture, and cosmetics

+ Antioxidant

Exhibits antioxidant properties, which can help protect cells from damage caused by free radicals

+ Anti-inflammatory

Has been found to exhibit anti-inflammatory properties, which can help reduce inflammation and swelling

+ Anti-microbial

Exhibits anti-microbial properties, which can help inhibit the growth of harmful microorganisms

+ Plant growth enhancement

Has been shown to enhance plant growth and stress tolerance, making it a promising natural alternative to synthetic growth regulators

+ Valuable chemical compound

Its diverse range of properties and potential applications make 15-Nonacosanol a valuable chemical compound for further research and development.

Upstream product

• 2764-73-0 nonacosan-15-one 
• 112-71-0 1-Bromotetradecane 
• 109-94-4 formic acid ethyl ester 
• 4347-23-3 tetradecyllithium 

Relevant articles and documents

LIPIDOSOME PREPARATION, PREPARATION METHOD AND APPLICATION THEREOF

The present invention discloses a liposome formulation, its preparation method, and its application in the treatment of diseases caused by abnormal gene expression. The liposome formulation comprises complementary cationic lipid pairs, phospholipids, and long-circulating lipids. The method of preparing the liposome formulation comprises: mixing the complementary cationic lipid pairs with the phospholipid and the long-circulating lipid to generate pre-formed vesicles; and then mixing the pre-formed vesicles with the nucleic acid solution to generate the liposome-nucleic acid formulation. This liposome formulation provided by the present invention is easily prepared; and in the treatment of diseases caused by abnormal gene expression, the liposome formulation can be used to deliver in vivo therapeutic agents, including nucleic acids.

Synthesis and characteristics of biodegradable pyridinium amphiphiles used for in vitro DNA delivery

Pyridinium amphiphiles have found practical application for the delivery of DNA into eukaryotic cells. A general synthetic method starting from (iso)nicotinoyl chloride has been devised for the preparation of pyridinium amphiphiles based on (bio)degradable esters, allowing structural variation both in the hydrophobic part and in the headgroup area. By means of differential scanning calorimetry, transmission electron microscopy and UV measurements, some characteristics, including hydrolytic behaviour, have been determined. In vitro transfection ability and toxicity have been determined using the eukaryotic COS-7 cell line. Wiley-VCH Verlag GmbH, 69451 Weinheim, Germany, 2002.